| Entry |
|
|---|
| Name |
Dalvastatin (USAN/INN) |
|---|
| Formula |
C24H31FO3
|
|---|
| Exact mass |
386.2257
|
|---|
| Mol weight |
386.50
|
|---|
| Structure |
|
|---|
| Class |
Hypolipidemic agent
DG01946 Hypolipidemic agent
DG01660 HMG-CoA reductase inhibitor
|
|---|
| Efficacy |
Antihyperlipidemic, HMG-CoA reductase inhibitor |
|---|
| Target |
|
|---|
| Pathway |
| hsa00900 | Terpenoid backbone biosynthesis |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Hypolipidemic agent
DG01946 Hypolipidemic agent
DG01660 HMG-CoA reductase inhibitor
D03643 Dalvastatin
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Dehydrogenases
HMGCR
D03643 Dalvastatin (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 28
1 C1y C 19.8162 -12.0428
2 C1x C 19.8162 -13.4430
3 C1y C 21.0288 -14.1432
4 O7x O 22.2415 -13.4430
5 C7x C 22.2415 -12.0428
6 C1x C 21.0288 -11.3426
7 C2b C 21.0288 -15.5434
8 C2b C 19.7995 -16.2534
9 C2y C 19.7995 -17.6536
10 C2y C 18.6035 -18.3441
11 C1x C 18.6035 -19.7443
12 C1z C 19.8163 -20.4445
13 C1x C 21.0121 -19.7540
14 C1z C 21.0121 -18.3538
15 C8y C 17.4077 -17.6535
16 C8x C 17.4077 -16.2439
17 C8x C 16.1951 -15.5437
18 C8y C 14.9824 -16.2439
19 C8y C 14.9825 -17.6535
20 C8x C 16.1951 -18.3537
21 X F 13.7717 -15.5449
22 C1a C 13.7761 -18.3500
23 O1a O 18.6035 -11.3426
24 O6a O 23.4729 -11.3316
25 C1a C 18.6038 -21.1445
26 C1a C 21.0287 -21.1445
27 C1a C 21.7121 -17.1413
28 C1a C 22.0020 -19.3437
BOND 30
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 3 7 1 #Up
8 7 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 9 14 1
16 10 15 1
17 15 16 2
18 16 17 1
19 17 18 2
20 18 19 1
21 19 20 2
22 15 20 1
23 18 21 1
24 19 22 1
25 1 23 1 #Down
26 5 24 2
27 12 25 1
28 12 26 1
29 14 27 1
30 14 28 1
|
|---|
